Helicobacter pylori test &amp; treat strategy for dyspepsia: a qualitative study exploring the barriers and how to overcome them

McNulty, C.; Freeman, Elaine; Delaney, Brendan

doi:10.1093/fampra/cmi107

Cited by 4 publications

(6 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…69 McNulty et al 106 explored the views of primary care about introducing the H. pylori test-and-treat strategy and found that staff preferred stool tests to breath tests, as they impacted less on practice budget and time. On the other hand, stool antigen testing may be somewhat less acceptable to patients.…”

Section: Type Of Diagnostic Methods To Detect H Pylori Infectionmentioning

confidence: 99%

“…195 Authors who explored the introduction of test-and-treat from the perspective of primary care found that primary care health staff reported that the major barrier to the introduction of NICE test-and-treat guidance for patients with dyspepsia was the time taken to give patients information on testing, test results, and treatment and the impact on nurses' time. 106 …”

Section: Implementation Of Guidelines In Clinical Practicementioning

confidence: 99%

See 1 more Smart Citation

Helicobacter Pylori “Test-and-Treat” Strategy for Management of Dyspepsia: A Comprehensive Review

Gisbert

Calvet

2013

Clinical and Translational Gastroenterology

View full text Add to dashboard Cite

OBJECTIVES:Deciding on whether the Helicobacter pylori test-and-treat strategy is an appropriate diagnostic–therapeutic approach for patients with dyspepsia invites a series of questions. The aim present article addresses the test-and-treat strategy and attempts to provide practical conclusions for the clinician who diagnoses and treats patients with dyspepsia.METHODS:Bibliographical searches were performed in MEDLINE using the keywords Helicobacter pylori, test-and-treat, and dyspepsia. We focused mainly on data from randomized controlled trials (RCTs), systematic reviews, meta-analyses, cost-effectiveness analyses, and decision analyses.RESULTS:Several prospective studies and decision analyses support the use of the test-and-treat strategy, although we must be cautious when extrapolating the results from one geographical area to another. Many factors determine whether this strategy is appropriate in each particular area. The test-and-treat strategy will cure most cases of underlying peptic ulcer disease, prevent most potential cases of gastroduodenal disease, and yield symptomatic benefit in a minority of patients with functional dyspepsia. Future studies should be able to stratify dyspeptic patients according to their likelihood of improving after treatment of infection by H. pylori.CONCLUSIONS:The test-and-treat strategy will cure most cases of underlying peptic ulcer disease and prevent most potential cases of gastroduodenal disease. In addition, a minority of infected patients with functional dyspepsia will gain symptomatic benefit. Several prospective studies and decision analyses support the use of the test-and-treat strategy. The test-and-treat strategy is being reinforced by the accumulating data that support the increasingly accepted idea that “the only good H. pylori is a dead H. pylori”.

show abstract

Section: Type Of Diagnostic Methods To Detect H Pylori Infectionmentioning

confidence: 99%

Section: Implementation Of Guidelines In Clinical Practicementioning

confidence: 99%

Helicobacter Pylori “Test-and-Treat” Strategy for Management of Dyspepsia: A Comprehensive Review

Gisbert

Calvet

2013

Clinical and Translational Gastroenterology

View full text Add to dashboard Cite

show abstract

“…Patients might not come back to bring the stool specimen; however, the blood test or UBT can be done before they leave. [74]…”

Section: Preventative Measuresmentioning

confidence: 99%

Helicobacter pylori infection in developing countries: The burden for how long?

Salih

2009

Saudi J Gastroenterol

202

135

View full text Add to dashboard Cite

Approximately 50% (over 3 billion) of the world populations are known to be infected with Helicobacter pylori, mainly in the developing countries. Among those, hundreds of millions of people develop peptic ulceration during their lifetime and still tens of millions might progress to gastric cancer. Possible modes of H. pylori transmission generally described are through direct contact between family members and also through contaminated water and food. Because the high prevalence of infection occurs mainly in developing countries and because the test-and-treat strategy puts a huge economic burden on many of these countries, it is time to take an immediate action toward this bacterial infection and adopt a strategy to prevent it. To address this issue, an updated prevalence of infection, modes of transmission, economics of infection and preventative measures to block the infection process have been discussed.

show abstract

“…Despite being told the breath test incurred a prescription charge, more respondents preferred the breath test (58%) to stool test (34%). GPs have reported that the breath test is too time-consuming for them to perform routinely in the practice setting 9 and, at 2005 costs, it is also more expensive than the stool test. Half of employed participants took time off from work and 80% required an extra appointment for their blood test.…”

Section: Discussionmentioning

confidence: 99%

“…7,8 GPs have suggested that patients and practices would accept stool testing if appropriately counselled about the improved accuracy over blood serology, and the ease of implementation in the practice setting. 9 There have not been any UK studies examining the acceptability of helicobacter stool tests. Patient compliance with opportunistic faecal occult blood testing in asymptomatic general practice patients reached 56% in a large Birmingham study 10 ; acceptance in symptomatic patients is likely to be much higher.…”

Section: Introductionmentioning

confidence: 99%

Patients' attitudes to Helicobacter pylori breath and stool antigen tests compared to blood serology

McNulty

Whiting²

2007

Journal of Infection

View full text Add to dashboard Cite

Helicobacter pylori test & treat strategy for dyspepsia: a qualitative study exploring the barriers and how to overcome them

Cited by 4 publications

References 9 publications

Helicobacter Pylori “Test-and-Treat” Strategy for Management of Dyspepsia: A Comprehensive Review

Helicobacter Pylori “Test-and-Treat” Strategy for Management of Dyspepsia: A Comprehensive Review

Helicobacter pylori infection in developing countries: The burden for how long?

Patients' attitudes to Helicobacter pylori breath and stool antigen tests compared to blood serology

Contact Info

Product

Resources

About